Science

Microdosing Finding Awe: Microdosing, Connectedness, and Transformation
As research around the efficacy of psychedelics expands, it’s possible microdosing could serve as the missing link to pull us all together.
Tessa Love · January 20th, 2021
Ketamine Ketamine vs. Antidepressants: What’s the Research Say?
As depression continues weaving its insidious web, those who suffer need hope. Fortunately, a growing wave of research points to ketamine therapy as a viable alternative.
Elena Schmidt · November 12th, 2020
Mainstream Society It Ain’t So “Psilly”: Facing Down Depression With Psilocybin
If you or someone you care about is one of the 264 million people worldwide who struggle with depression, then you’re likely familiar with the two primary standards of treatment: psychological therapy and pharmaceuticals. There’s no doubt that many people have been helped by these methods, especially in conjunction. But what if there were something better? 
Shannon Calderon · November 10th, 2020
Mindfulness Can Psilocybin Help Us Face Our Greatest Fears?
New studies show that psilocybin may be effective in helping us overcome existential fears.
Samuel Douglas · October 14th, 2020
Community Overcoming Anxiety with Psychedelic Integration
Recent studies show progress in treatment of depression, PTSD, and anxiety, could psychedelics also be the answer for those suffering from social anxiety?
Bre Jenkins · October 12th, 2020
Community Are You Seeking Psychedelic Support?
What’s the difference between a psychedelic guide, trip sitter, coach, and therapist?
Bre Jenkins · October 5th, 2020
Mainstream Society Apollo Neuro is Like a Microdose on Your Wrist
Science has found vibrations of certain wavelengths and tempos, based on breathing patterns, meditation, touch, and music, quickly relax the body and mind.
Paul Austin · September 14th, 2020
Harm Reduction Transcript: Connection Through Chemistry – Dr. Julie Holland, M.D.
Dr. Julie Holland, psychopharmacology specialist, discusses oxytocin, music, death, and using psychedelics to activate our parasympathetic nervous system.
Third Wave · July 19th, 2020
Microdosing Two Organizations Focused on Microdosing Research Announce Partnership
The world is wondering what to do with psilocybin, one of the most promising drugs in the world. Three cities—Denver, […]
Third Wave · February 25th, 2020
Psilocybin Beta-Carboline Alkaloids Found in Psilocybe Mushrooms
A recent study reported the presence of beta-carboline MOAI alkaloids in psilocybin mushrooms. These compounds are well known for being the key […]
Paul Austin · January 28th, 2020
Psilocybin FDA Grants Breakthrough Therapy Designation to Psilocybin Therapy for Major Depressive Disorder
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Usona Institute’s Phase II psilocybin trials for major depressive disorder. […]
Paul Austin · December 28th, 2019
LSD LSD Microdosing Trial Approved in New Zealand
The first of its kind, it will enroll 40 men to determine the effects of LSD microdosing in a naturalistic setting.
Paul Austin · December 1st, 2019
Science Johns Hopkins Opens World’s Biggest Psychedelic Research Center
Johns Hopkins University announces the opening of the world's largest research center devoted to studying psychedelic substances, backed by $17 million in private donations.
Paul Austin · September 5th, 2019
Microdosing The Third Wave’s Guide to Microdosing Research
In our comprehensive overview of microdosing research, learn what science has proven about this nascent practice.
Erin Ginder-Shaw · July 24th, 2019
Microdosing Microdosing Psychedelics Linked to Better Mood and Focus in Two New Research Papers
Two published research papers help us further understand the benefits and drawbacks of integrating microdosing into everyday life.
Paul Austin · July 17th, 2019